Stockholders' Equity

12 Months Ended

Dec. 31, 2025

Stockholders’ Equity [Abstract]

Stockholders' Equity

Note 18.  Stockholders’ Equity

Capital Stock

The Company’s authorized capital stock consists of 100 million shares of common stock, par value $0.10 per share, of which 31,034,106 shares and 31,895,655 shares were outstanding at December 31, 2025 and 2024, respectively, and 1,000,000 shares of preferred stock, none of which were issued and outstanding.

Cash Dividends

Cash dividends of $14.2 million or $0.45 per common share were paid during 2025. In January 2026, a cash dividend of approximately $3.7 million or $0.12 per share, was declared, payable in the first quarter of 2026.

Stock Award and Incentive Plan

The Company’s 2015 Stock Award and Incentive Plan provides for grants of incentive and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, stock awards, and performance unit awards (the 2015 Stock Award and Incentive Plan, as amended, referred to herein as the “Plan” and together with its predecessor for awards granted prior to May 2015, the 2001 Stock Award and Incentive Plan, as amended and restated, the “Plans”). At the Company's 2024 Annual Meeting of Stockholders, the Company's stockholders ratified the adoption of an amendment and restatement of the Plan, which increased the number of shares available for issuance pursuant to the Plan by 889,000 shares and removed certain individual award limits in light of recent tax law changes. The Plans are administered by the Compensation Committee of the Board of Directors. Stock options granted under the Plans generally have a ten-year term. The exercise price for stock options are at prices at or above the fair market value of the common stock on the date of the grant, and each award of stock options will vest ratably over a specified period, generally three years.

The following table summarizes stock option and restricted stock unit activity for the Plans:

			Stock Options					Restricted Stock Units
	Shares						Weighted Average					Weighted Average
	Available						Exercise Price					Exercise Price
	for Grant			Shares			per Share ($)		Shares			per Share ($)
Balance January 1, 2023	1,080,460			1,363,418		$	62.22		176,594		$	66.32
Authorized	-			-			-		-			-
Granted	(358,463	)		255,620			66.08		102,843			66.01
Exercised/vested	-			(91,604	)		56.82		(46,141	)		64.25
Canceled	58,918			(12,972	)		67.54		(45,946	)		64.33
Balance December 31, 2023	780,915			1,514,462			63.15		187,350			67.15
Authorized	889,000			-			-		-			-
Granted	(299,640	)		196,471			66.72		103,169			66.79
Exercised/vested	-			(279,810	)		55.85		(47,876	)		67.19
Canceled	49,336			(5,487	)		66.76		(43,849	)		67.21
Balance December 31, 2024	1,419,611			1,425,636			65.06		198,794			66.94
Authorized	-			-			-		-			-
Granted	(268,623	)		174,874			76.75		93,749			76.55
Exercised/vested	-			(56,110	)		42.40		(50,146	)		67.38
Canceled	80,912			(28,015	)		70.06		(52,897	)		67.40
Balance December 31, 2025	1,231,900			1,516,385		$	67.16		189,500		$	71.45